Skip to main content
Press Release

Court Imposes Restrictions on Alcohol Addiction Treatment Company to Protect Consumers’ Private Information

For Immediate Release
Office of Public Affairs

The Justice Department and the Federal Trade Commission (FTC) announced today that a federal court in Washington, D.C., has entered a settlement that prohibits alcohol addiction treatment company Monument Inc. (Monument) from misrepresenting its data privacy practices and disclosing its customers’ health information to third parties for advertising purposes, and also requires the company to take several measures to safeguard its customers’ personal information. The court also entered a $2.5 million civil penalty judgment against Monument, which is suspended due to the company's inability to pay.

A civil complaint filed today alleges that Monument violated the Federal Trade Commission Act and the Opioid Addiction Recovery Fraud Prevention Act of 2018 by misrepresenting on its alcohol addiction treatment website and elsewhere that it would not disclose its customers’ health information without their express consent and by failing to employ reasonable measures to protect its customers’ data. The complaint alleges that such failures led Monument to disclose thousands of users’ health information to third parties for advertising or other purposes.

“Treatment for substance abuse and addiction is highly personal and sensitive, and companies providing such services must be especially vigilant in safeguarding their customers’ information,” said Principal Deputy Assistant Attorney General Brian M. Boynton, head of the Justice Department’s Civil Division. “The Justice Department is committed to working with the FTC to protect Americans’ sensitive information.”

“This action continues the FTC’s work to ensure strict limits on how firms handle sensitive health data, rather than putting the onus on consumers to protect themselves,” said Director Samuel Levine of the FTC’s Bureau of Consumer Protection. “Following on the heels of actions against GoodRx, BetterHelp and Premom, the market should be getting the message that consumer health data should be handled with extreme caution.”

Senior Trial Attorney Richard Greene and Assistant Director Zachary Dietert of the Civil Division's Consumer Protection Branch are handling this matter, working in conjunction with staff at the FTC’s Division of Privacy and Identity Protection.

For more information about the Consumer Protection Branch and its enforcement efforts, visit www.justice.gov/civil/consumer-protection-branch. For more information about the FTC, visit www.FTC.gov.

Updated June 7, 2024

Press Release Number: 24-716